Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Grant Will Help Reduce Incidence of Johne's Disease in Dairy Cows

Published: Tuesday, January 08, 2013
Last Updated: Tuesday, January 08, 2013
Bookmark and Share
Dangerous bacterium in milk could also be linked to Crohn’s disease in humans.

Every day, more than 16 million gallons of milk are consumed in the United States. However, despite the technology and safety standards in place, some of that milk contains a nasty bacterium that is linked to Johne's disease in cattle and possibly Crohn's disease in people.

A new $500,000 grant over five years from the U.S. Department of Agriculture's National Institute of Food and Agriculture will allow Cornell researchers to continue their research to identify the bacterium in milk, determine risk factors for milk contamination and document recommended intervention strategies to make milk safer.

The bacterium, known as Mycobacterium avium subspecies paratuberculosis or MAP, incites an infection in ruminant animals that takes about four years to show clinical signs. In the meantime, dairy cows typically have had two calves during that period that may have contracted the infection from their mothers and have produced thousands of gallons of milk headed for store shelves. Recent studies have shown that MAP in milk can survive pasteurization, which has raised human health concerns due to the widespread nature of MAP in modern dairy herds.

Once MAP has infiltrated a herd, the cows are widely susceptible to Johne's disease, which is contagious, chronic and often fatal in cases of clinical disease. The disease is blamed for up to $250 million in annual losses to the U.S. dairy industry.

The new grant will build on the results of the current $2.5 million project, which has been under way since 2009.

The researchers are in the midst of a nine-year longitudinal study to gather DNA from four generations of cows and bacteria, said Ynte Schukken, principal investigator and professor of epidemiology and herd health at Cornell's College of Veterinary Medicine.

"Our study covers the entire spectrum, with data and samples collected from the field cultured in the lab, and bacteria and host DNA sequenced using the most modern genomic methods," Schukken said. "Because of this unparalleled nine-year data set, we have the potential to unravel the mysteries of Johne's disease, a very slow-going and devastating infection on dairy farms."

The researchers, which includes Cornell's Yrjo Grohn, professor of population medicine and diagnostic science, and scientists from Penn State University, the University of Pennsylvania and the University of Maryland, will:

•    validate the use of a current test used to identify MAP;
•    analyze data from two herds with a known MAP infection prevalence and cross-sectional data from 300 dairy herds with the complete range of MAP infection prevalence, focusing on the relationship between management practices and MAP contamination of milk;
•    develop risk assessment models that explain and predict MAP contamination of raw milk; and
•    use models they have developed to design optimal sustainable MAP-free milk programs.

Schukken's investigation will extend prior results that have already explained transmission patterns of MAP at the molecular level, developed mathematical models for predicting transmission, devised control programs and monitored those programs' success rates.

"Our immediate goal is to provide dairy farmers with the tools they need to produce milk that is free of MAP bacteria," said Schukken. "Evidence from previous work we've done proves that a high percentage of dairy farms in the U.S. have MAP-infected cattle, so reducing viable MAP in raw and pasteurized milk is of importance. First for the health and well-being of the cows, but also, because of the possible connections to Crohn's disease, for the health and well-being of people."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Wednesday, June 29, 2016
Pathogen Takes Control of Gypsy Moth Populations
A new fungal pathogen is killing gypsy moth caterpillars and crowding out communities of pathogens and parasites that previously destroyed these moth pests.
Tuesday, April 26, 2016
Eating Green Could be in Your Genes
Genetic variation uncovered that has evolved in populations that have historically favored vegetarian diets, such as in India, Africa and parts of East Asia.
Friday, April 01, 2016
$4.8M USAID Grant to Improve Food Security
To strengthen capacity to develop and disseminate genetically engineered eggplant in Bangladesh and the Philippines, the USAID has awarded Cornell a $4.8 million, three-year cooperative grant.
Friday, April 01, 2016
Proteins Seek, Attack, Destroy Tumor Cells in Bloodstream
Using white blood cells to ferry potent cancer-killing proteins through the bloodstream virtually eliminates metastatic prostate cancer in mice, Cornell researchers have confirmed.
Friday, January 15, 2016
Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
Synthetic Immune Organ Produces Antibodies
Cornell engineers have created a functional, synthetic immune organ that produces antibodies and can be controlled in the lab, completely separate from a living organism.
Friday, June 12, 2015
On Planes, Savory Tomato Becomes Favored Flavor
Study shows the effect that airplane noise has on passengers' taste preferences.
Friday, May 15, 2015
$5.5M NSF Grant Aims to Improve Rice Crops with Genome Editing
Researchers to precisely target, cut, remove and replace DNA in a living cell to improve rice.
Friday, May 08, 2015
'Shield' Gives Tricky Proteins a New Identity
Solubilization of Integral Membrane Proteins with high Levels of Expression.
Saturday, April 11, 2015
DNA Safeguard May Be Key In Cancer Treatment
Cornell researchers have developed a new technique to understand the actions of key proteins required for cancer cells to proliferate.
Monday, March 09, 2015
A ‘STAR’ is Born: Engineers Devise Genetic 'On' Switch
A new “on” switch to control gene expression has been developed by Cornell scientists.
Tuesday, February 03, 2015
Bacteria Be Gone!
New technology keeps bacteria from sticking to surfaces.
Monday, January 19, 2015
On the Environmental Trail of Food Pathogens
Learning where Listeria dwells can aid the search for other food pathogens.
Tuesday, December 23, 2014
Chemists Show That ALS is a Protein Aggregation Disease
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers at Cornell have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis (ALS).
Thursday, October 23, 2014
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!